The Sodium Iodide Symporter (NIS) as an Imaging Reporter for Gene, Viral, and Cell-based Therapies
暂无分享,去创建一个
S. Russell | A. R. Penheiter | S. K. Carlson | Stephen J Russell | Alan R Penheiter | Stephanie K Carlson | A. Penheiter
[1] N. Carrasco,et al. Iodide transport in the thyroid gland. , 1993, Biochimica et biophysica acta.
[2] D. Lee,et al. Visualization of Hypoxia-Inducible Factor-1 Transcriptional Activation in C6 Glioma Using Luciferase and Sodium Iodide Symporter Genes , 2008, Journal of Nuclear Medicine.
[3] Keiichi Magota,et al. Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[4] D. Dingli,et al. Interaction of measles virus vectors with Auger electron emitting radioisotopes. , 2005, Biochemical and biophysical research communications.
[5] R. Boisgard,et al. Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine-pancreas gene as a liver tumor-specific promoter. , 2008, Human gene therapy.
[6] A. Bockisch,et al. Quantitative imaging of (124)I with PET/ CT in pretherapy lesion dosimetry. Effects impairing image quantification and their corrections. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[7] Paul K. Marsden,et al. Synthesis and biological evaluation of [18F]tetrafluoroborate: a PET imaging agent for thyroid disease and reporter gene imaging of the sodium/iodide symporter , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[8] K. Harrington,et al. SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene , 2007, Gene Therapy.
[9] Kah-Whye Peng,et al. Viruses as anticancer drugs. , 2007, Trends in pharmacological sciences.
[10] D. Tindall,et al. Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[11] D. Lee,et al. Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[12] S. Filetti,et al. Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients , 2007, Nature Clinical Practice Endocrinology &Metabolism.
[13] H. Hricak,et al. Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene , 2009, Clinical Cancer Research.
[14] D. Dingli,et al. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. , 2004, Blood.
[15] C. Spitzweg,et al. The sodium iodide symporter: its pathophysiological and therapeutic implications , 2002, Clinical endocrinology.
[16] S. Cherry,et al. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals , 1999, Gene Therapy.
[17] H. Herschman. Noninvasive imaging of reporter gene expression in living subjects. , 2004, Advances in cancer research.
[18] M. Hays,et al. Pertechnetate distribution in man after intravenous infusion: a compartmental model. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[19] Stephen L. Brown,et al. GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[20] R. Blasberg,et al. Imaging of HSV-tk Reporter Gene Expression: Comparison Between [18F]FEAU, [18F]FFEAU, and Other Imaging Probes , 2008, Journal of Nuclear Medicine.
[21] M. O’Connor,et al. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. , 2006, Human gene therapy.
[22] M. Gonen,et al. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus , 2011, Journal of Translational Medicine.
[23] John C. Morris,et al. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer , 2009, Breast Cancer Research.
[24] G. Nikiforidis,et al. In vivo small animal imaging: current status and future prospects. , 2010, Medical physics.
[25] Kyung-Han Lee,et al. Accuracy of myocardial sodium/iodide symporter gene expression imaging with radioiodide: evaluation with a dual-gene adenovirus vector. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] R. Wahl,et al. Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. , 2008, Journal of the American College of Cardiology.
[27] T. Endo,et al. Cloning of malignantly transformed rat thyroid (FRTL) cells with thyrotropin receptors and their growth inhibition by 3',5'-cyclic adenosine monophosphate. , 1990, Endocrinology.
[28] M. O’Connor,et al. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice , 2006, Gene Therapy.
[29] P Hendrik Pretorius,et al. Introduction to the physics of molecular imaging with radioactive tracers in small animals , 2002, Journal of cellular biochemistry. Supplement.
[30] E. Galanis,et al. Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview. , 2009, Current opinion in molecular therapeutics.
[31] D. Kirn,et al. Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval. , 2010, Cytokine & growth factor reviews.
[32] R Weissleder,et al. New approaches for imaging in gene therapy. , 2000, European journal of radiology.
[33] Arion F. Chatziioannou,et al. Instrumentation for Molecular Imaging in Preclinical Research , 2012 .
[34] J. Cho,et al. Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy , 2004, Gene Therapy.
[35] N. Carrasco,et al. The Na+/I- symporter mediates active iodide uptake in the intestine. , 2009, American journal of physiology. Cell physiology.
[36] H. Sakahara,et al. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[37] D. Dingli,et al. Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy , 2010, Cancer Gene Therapy.
[38] M. Vähä-Koskela,et al. Novel oncolytic viruses: riding high on the next wave? , 2010, Cytokine & growth factor reviews.
[39] S. Fineberg,et al. The mammary gland iodide transporter is expressed during lactation and in breast cancer , 2000, Nature Medicine.
[40] R. Blasberg,et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[41] R. Hichwa,et al. Noninvasive radiological imaging of pulmonary gene transfer and expression using the human sodium iodide symporter , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[42] A. Melcher,et al. The biology of the sodium iodide symporter and its potential for targeted gene delivery. , 2010, Current cancer drug targets.
[43] U. Haberkorn,et al. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[44] Rui Qin,et al. A Probasin Promoter, Conditionally Replicating Adenovirus that Expresses the Sodium Iodide Symporter (NIS) for Radiovirotherapy of Prostate Cancer , 2010, Gene Therapy.
[45] D. Ingram,et al. In vivo assessment of adenoviral vector‐mediated gene expression of dopamine D2 receptors in the rat striatum by positron emission tomography , 2002, Synapse.
[46] A. De la Vieja,et al. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. , 2000, Physiological reviews.
[47] Troy Farncombe,et al. An overview of attenuation and scatter correction of planar and SPECT data for dosimetry studies. , 2003, Cancer biotherapy & radiopharmaceuticals.
[48] D. Dingli,et al. Pinhole Micro-SPECT/CT for Noninvasive Monitoring and Quantitation of Oncolytic Virus Dispersion and Percent Infection in Solid Tumors , 2011, Gene Therapy.
[49] R. Blasberg,et al. Imaging hNET Reporter Gene Expression with 124I-MIBG , 2007, Journal of Nuclear Medicine.
[50] E. Pearce,et al. Perchlorate, iodine and the thyroid. , 2010, Best practice & research. Clinical endocrinology & metabolism.
[51] C. Serrano-Nascimento,et al. Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration. , 2010, American journal of physiology. Cell physiology.
[52] C. Ginter,et al. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. , 2003, Endocrine reviews.
[53] P. Gerundini,et al. The trapping-only nodules of the thyroid gland: prevalence study. , 2006, Thyroid : official journal of the American Thyroid Association.
[54] J. Voges,et al. Methods to monitor gene therapy with molecular imaging. , 2009, Methods.
[55] P. Yen,et al. Physiological and molecular basis of thyroid hormone action. , 2001, Physiological reviews.
[56] N. Lemoine,et al. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. , 2002, Human gene therapy.
[57] G. Vassaux,et al. Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy , 2010, British journal of pharmacology.
[58] H. Hricak,et al. Different Strategies for Reducing Intestinal Background Radioactivity Associated with Imaging HSV1-tk Expression Using Established Radionucleoside Probes , 2010, Molecular imaging.
[59] M. O’Connor,et al. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. , 2007, Human gene therapy.
[60] Kathryn E. Luker,et al. Optical Imaging: Current Applications and Future Directions , 2007, Journal of Nuclear Medicine.
[61] A. Signore,et al. In vivo biodistribution of stem cells using molecular nuclear medicine imaging , 2011, Journal of cellular physiology.
[62] B. Czarnocka. Thyroperoxidase, thyroglobulin, Na(+)/I(-) symporter, pendrin in thyroid autoimmunity. , 2011, Frontiers in bioscience.
[63] R. Senekowitsch-Schmidtke,et al. α-Fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma , 2008, Gene Therapy.
[64] Xin He,et al. Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma. , 2011, Tumori.
[65] M. Scheunemann,et al. Comparison of [18F]FHPG and [124/125I]FIAU for imaging herpes simplex virus type 1 thymidine kinase gene expression , 2001, European Journal of Nuclear Medicine.
[66] H. E. Palmer,et al. Distribution and excretion of technetium in humans. , 1966, Health physics.
[67] C. O'Neill,et al. Standard and emerging therapies for metastatic differentiated thyroid cancer. , 2010, The oncologist.
[68] Qing-Rong Liu,et al. Cloning of the human sodium lodide symporter. , 1996, Biochemical and biophysical research communications.
[69] J. Parry,et al. MicroPET imaging of gene transfer with a somatostatin receptor-based reporter gene and (94m)Tc-Demotate 1. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[70] C. Spitzweg,et al. Gene therapy for thyroid cancer: current status and future prospects. , 2004, Thyroid : official journal of the American Thyroid Association.
[71] B. Keil,et al. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[72] M. Black,et al. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[73] A Del Guerra,et al. Advances in animal PET scanners. , 2002, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[74] P. Acton,et al. Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation* , 2008, Journal of Nuclear Medicine.
[75] C. Spitzweg,et al. Thyroid iodine transport. , 2000, Thyroid : official journal of the American Thyroid Association.
[76] C. Spitzweg,et al. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. , 1999, The Journal of clinical endocrinology and metabolism.
[77] R. Kloos,et al. Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography , 2004, Cancer Gene Therapy.
[78] H. Youn,et al. A new PET probe, 18F-tetrafluoroborate, for the sodium/iodide symporter: possible impacts on nuclear medicine , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[79] S. Russell,et al. History of oncolytic viruses: genesis to genetic engineering. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[80] S. Nekolla,et al. Reporter Gene PET for Monitoring Survival of Transplanted Endothelial Progenitor Cells in the Rat Heart After Pretreatment with VEGF and Atorvastatin , 2009, Journal of Nuclear Medicine.
[81] R G Blasberg,et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. , 1996, Cancer research.
[82] David Dingli,et al. Genetically targeted radiotherapy for multiple myeloma. , 2003, Blood.
[83] C. Spitzweg,et al. Cloning of the mouse sodium iodide symporter. , 2001, Thyroid : official journal of the American Thyroid Association.
[84] M. Perricaudet,et al. Long-Term Radioiodine Retention and Regression of Liver Cancer after Sodium Iodide Symporter Gene Transfer in Wistar Rats , 2004, Cancer Research.
[85] Gary D Luker,et al. Molecular imaging of gene expression and protein function in vivo with PET and SPECT , 2002, Journal of magnetic resonance imaging : JMRI.
[86] K. Neve,et al. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. , 1991, Molecular pharmacology.
[87] F. Mottaghy,et al. Effect of the positron range of 18F, 68Ga and 124I on PET/CT in lung-equivalent materials , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[88] Stephen L. Brown,et al. Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[89] Youngho Seo,et al. Rodent brain imaging with SPECT/CT. , 2007, Medical physics.
[90] T. Endo,et al. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene. , 1997, Endocrinology.
[91] K. Harrington,et al. Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter , 2009, Clinical Cancer Research.
[92] D. Moon,et al. Imaging of human sodium-iodide symporter gene expression mediated by recombinant adenovirus in skeletal muscle of living rats , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[93] Andrew J Reader,et al. Performance evaluation of the 32-module quadHIDAC small-animal PET scanner. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[94] S. Russell,et al. Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene. , 2007, Blood.
[95] M. Josefsson,et al. Sodium/iodide-symporter: distribution in different mammals and role in entero-thyroid circulation of iodide. , 2002, Acta physiologica Scandinavica.
[96] J. Bidart,et al. Immunohistochemical analysis of Na+/I- symporter distribution in human extra-thyroidal tissues. , 1999, European journal of endocrinology.
[97] K. Harrington,et al. Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[98] R. Vile,et al. Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy. , 2001, The Journal of clinical endocrinology and metabolism.
[99] S. Refetoff,et al. Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism. , 1999, Biochimie.
[100] F. Sarkar,et al. Magnetic Resonance Imaging to Measure Therapeutic Response Using an Orthotopic Model of Human Pancreatic Cancer , 2000, Pancreas.
[101] F. Beekman,et al. U-SPECT-II: An Ultra-High-Resolution Device for Molecular Small-Animal Imaging , 2009, Journal of Nuclear Medicine.
[102] E.,et al. Clinical Nuclear Medicine , 1998, Springer US.
[103] Stephen L. Brown,et al. Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials. , 2007, Human gene therapy.
[104] K. Zinn,et al. The type 2 human somatostatin receptor as a platform for reporter gene imaging , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[105] M. O’Connor,et al. In vivo Radioiodide Imaging and Treatment of Breast Cancer Xenografts after MUC1-Driven Expression of the Sodium Iodide Symporter , 2005, Clinical Cancer Research.
[106] D. Curiel,et al. Current issues and future directions of oncolytic adenoviruses. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[107] C. Link,et al. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy , 2006, Gene Therapy.
[108] R. Blasberg,et al. Molecular imaging: reporter gene imaging. , 2008, Handbook of experimental pharmacology.
[109] Ling Lin,et al. Intracellular iodinated compounds affect sodium iodide symporter expression through TSH-mediated signaling pathways. , 2010, Molecular medicine reports.
[110] Stephen L. Brown,et al. A model for optimizing adenoviral delivery in human cancer gene therapy trials. , 2007, Human gene therapy.
[111] C. Spitzweg,et al. Expression of the sodium iodide symporter in human kidney. , 2001, Kidney international.
[112] J. Hoppin,et al. In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[113] Frans van der Have,et al. The pinhole: gateway to ultra-high-resolution three-dimensional radionuclide imaging , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[114] J. Morris,et al. The sodium-iodide symporter. , 2004, Current drug targets. Immune, endocrine and metabolic disorders.
[115] Simon R Cherry,et al. Small-animal preclinical nuclear medicine instrumentation and methodology. , 2008, Seminars in nuclear medicine.
[116] D. Ingram,et al. In vivo imaging of adenovirus‐mediated over‐expression of dopamine D2 receptors in rat striatum by positron emission tomography , 2000, Neuroreport.
[117] S. Jeong,et al. Trafficking Macrophage Migration Using Reporter Gene Imaging with Human Sodium Iodide Symporter in Animal Models of Inflammation , 2010, The Journal of Nuclear Medicine.
[118] D. Lee,et al. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[119] M. Miyagawa,et al. Cardiac reporter gene imaging using the human sodium/iodide symporter gene. , 2005, Cardiovascular research.
[120] J. Mountz,et al. A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. , 2001, Gynecologic oncology.
[121] D. Lee,et al. Development of a sodium/iodide symporter (NIS)-transgenic mouse for imaging of cardiomyocyte-specific reporter gene expression. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[122] Brendan Vastenhouw,et al. Targeted multi-pinhole SPECT , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[123] U. Haberkorn,et al. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose , 2003, Gene Therapy.
[124] P. Blower,et al. Evaluation of [18F]-tetrafluoroborate as a potential PET imaging agent for the human sodium/iodide symporter in a new colon carcinoma cell line, HCT116, expressing hNIS , 2011, Nuclear medicine communications.
[125] R. Mandell,et al. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. , 1999, Cancer research.
[126] B. Weintraub,et al. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. , 2002, Physiological reviews.
[127] G. Shambaugh,et al. Disparate thyroid imaging. Combined studies with sodium pertechnetate Tc 99m and radioactive iodine. , 1974, JAMA.
[128] Lung-Kwang Pan,et al. Effective half life of iodine for five thyroidectomy patients using an in vivo gamma camera approach. , 2007, Journal of radiation research.
[129] M. Schwaiger,et al. Use of the norepinephrine transporter as a reporter gene for non‐invasive imaging of genetically modified cells , 2004, The journal of gene medicine.
[130] L. Strauss,et al. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[131] N. Satyamurthy,et al. Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction , 2001, Gene Therapy.
[132] M. Hays. Kinetics of the human thyroid trap: a compartmental model. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[133] Mark Lubberink,et al. Quantitative imaging of 124I and 86Y with PET , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[134] P. Opolon,et al. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. , 2000, Cancer research.
[135] S. Russell,et al. Dual Therapy of Ovarian Cancer Using Measles Viruses Expressing Carcinoembryonic Antigen and Sodium Iodide Symporter , 2006, Clinical Cancer Research.
[136] U. Haberkorn,et al. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[137] K. Peng,et al. Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genome , 2009, The journal of gene medicine.
[138] C. Strisciuglio,et al. Noninvasive repetitive imaging of somatostatin receptor 2 gene transfer with positron emission tomography. , 2011, Human gene therapy.
[139] J. Kang,et al. Translational research using the sodium/iodide symporter in imaging and therapy , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[140] T J Spinks,et al. The design and physical characteristics of a small animal positron emission tomograph. , 1995, Physics in medicine and biology.
[141] P. Hou,et al. Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways. , 2010, The Journal of clinical endocrinology and metabolism.
[142] C. Spitzweg,et al. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations , 2010, Molecular and Cellular Endocrinology.
[143] D. Rottenberg,et al. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. , 1982, Science.
[144] Xiaowei Liu,et al. A 3-dimensional absorbed dose calculation method based on quantitative SPECT for radionuclide therapy: evaluation for (131)I using monte carlo simulation. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[145] N. Carrasco,et al. Cloning and characterization of the thyroid iodide transporter , 1996, Nature.
[146] M. Hays. Kinetics of the human thyroid trap: effects of iodide, thyrotropin, and propylthiouracil. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[147] V. Lowe,et al. In Vivo Quantitation of Intratumoral Radioisotope Uptake Using Micro-Single Photon Emission Computed Tomography/Computed Tomography , 2006, Molecular Imaging and Biology.
[148] Kent R Bailey,et al. Sodium Iodide Symporter (hNIS) Permits Molecular Imaging of Gene Transduction in Cardiac Transplantation , 2007, Transplantation.
[149] D. Curiel,et al. Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice. , 2002, Radiology.
[150] S. Larson,et al. Imaging transgene expression with radionuclide imaging technologies. , 2000, Neoplasia.
[151] S. Russell,et al. Non-invasive radioiodine imaging for accurate quantitation of NIS reporter gene expression in transplanted hearts. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[152] D. Tindall,et al. In vivo sodium iodide symporter gene therapy of prostate cancer , 2001, Gene Therapy.
[153] R. P. Spencer,et al. Thyroid carcinoma presenting as a pertechnetate "hot" nodule, but without 131I uptake: case report. , 1976, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[154] U. Haberkorn,et al. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[155] R. Senekowitsch-Schmidtke,et al. Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. , 2007, The Journal of clinical endocrinology and metabolism.
[156] J. Franklyn,et al. Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake. , 2011, The Journal of endocrinology.
[157] June-Key Chung,et al. Sodium iodide symporter: its role in nuclear medicine. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[158] C. Spitzweg,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Analysis of Human Sodium Iodide Symporter Gene Expression in Extrathyroidal Tissues and Cloning of Its Complementary Deoxyribonucleic Acids from S , 2022 .
[159] D. Dingli,et al. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. , 2004, Biochemical and Biophysical Research Communications - BBRC.
[160] Jaetae Lee,et al. Combination Therapy and Noninvasive Imaging with a Dual Therapeutic Vector Expressing MDR1 Short Hairpin RNA and a Sodium Iodide Symporter , 2008, Journal of Nuclear Medicine.
[161] Stephen L. Brown,et al. Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[162] Arion F Chatziioannou,et al. Instrumentation for molecular imaging in preclinical research: Micro-PET and Micro-SPECT. , 2005, Proceedings of the American Thoracic Society.
[163] P. Santisteban,et al. A perspective view of sodium iodide symporter research and its clinical implications. , 2006, European journal of endocrinology.
[164] R. Blasberg,et al. hNIS-IRES-eGFP Dual Reporter Gene Imaging , 2005, Molecular imaging.
[165] D. Lee,et al. In Vivo Imaging of Retinoic Acid Receptor Activity using a Sodium/Iodide Symporter and Luciferase Dual Imaging Reporter Gene , 2004, Molecular imaging.
[166] D. Tindall,et al. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. , 2000, Cancer research.
[167] A. Reader,et al. Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[168] L. Valenta. Metastatic thyroid carcinoma in man concentrating iodine without organification. , 1966, The Journal of clinical endocrinology and metabolism.
[169] M. Hays. 99m Tc-pertechnetate transport in man: absorption after subcutaneous and oral administration; secretion into saliva and gastric juice. , 1973, Journal of Nuclear Medicine.
[170] A. Lenzi,et al. Expression and localization of the sodium/iodide symporter (NIS) in testicular cells , 2011, Endocrine.
[171] J. Sakamoto,et al. Effect of thyroid statuses on sodium/iodide symporter (NIS) gene expression in the extrathyroidal tissues in mice , 2010, Thyroid research.
[172] A. Arzoumanian,et al. Thyroid nodule scans made with pertechnetate and iodine may give inconsistent results. , 1971, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[173] R. Hichwa,et al. Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[174] Comparison of 18F PET and 99mTc SPECT imaging in phantoms and in tumored mice. , 2010, Bioconjugate chemistry.
[175] E. Dadachova,et al. The Na/I symporter (NIS): imaging and therapeutic applications. , 2004, Seminars in nuclear medicine.
[176] D. Schellingerhout. Molecular imaging of novel cell- and viral-based therapies. , 2006, Neuroimaging clinics of North America.
[177] S. Jhiang,et al. Correlation of Na+/I- symporter expression and activity: implications of Na+/I- symporter as an imaging reporter gene. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[178] B. Movsas,et al. Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[179] S. Gambhir,et al. Comparison of [18F]FHBG and [14C]FIAU for imaging of HSV1-tk reporter gene expression: adenoviral infection vs stable transfection , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[180] B. Kemp,et al. Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene. , 2009, AJR. American journal of roentgenology.
[181] P. Kopp,et al. Minireview: The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. , 2009, Endocrinology.
[182] R. Blasberg,et al. Imaging the expression of transfected genes in vivo. , 1995, Cancer research.
[183] R. Cavalieri,et al. Uptake of technetium 99-pertechnetate in a primary thyroid carcinoma: need for caution in evaluating nodules. , 1970, The Journal of clinical endocrinology and metabolism.
[184] D. Dingli,et al. In vivo imaging and tumor therapy with the sodium iodide symporter , 2003, Journal of cellular biochemistry.
[185] Assaf A Gilad,et al. MRI Reporter Genes , 2008, Journal of Nuclear Medicine.